• Kyodo

  • SHARE

Documents leaked from an offshore law firm show a Japanese hospital and a doctor profited from unlisted shares in a Singapore medical firm, with the doctor profiting ¥100 million ($880,000) despite the hospital’s involvement in clinical trials for the company.

According to an analysis of the documents known as the “Paradise Papers,” doctors in the United States and India also bought unlisted shares in Biosensors International Group Ltd., a medical device company specializing in cardiovascular treatment. The firm was incorporated in Bermuda, a British island territory known as a tax haven.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)